|
Recent Newsletters
FDA clears temporary pacing guidewire for TAVR | More positive pulsed field ablation trial data |
TAVR Highlights: New biomimetic valve linked to strong 1-year outcomes | Warfarin vs. DAPT, SAPT |
Managing patients with SCAD | FDA says iRhythm committed multiple violations, failed to report deaths in time |
Structural Heart Disease Highlights: A historic heart procedure | Medtronic's TPV | TVT 2023 |
LBB pacing gaining momentum | Antithrombotic therapy after TAVR | Conformal Medical raises $35M |
FDA announces recall of certain Impella heart pumps | An expert's take on SOLVE-CRT | Novo Nordisk close to $165M deal |
News Alert: FDA announces recall of certain Impella heart pumps |